2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$7.39+$0.06 (+0.89%)
Price as of Aug 03, 2026 7:42 AM EDT- $1.2BMarket Cap
- 11.59%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$7.39+$0.06 (+0.89%)
Earnings Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 19.44% | ||
12-Month Momentum | 42.26% | ||
3-Month Risk Adjusted Momentum | 59.91% | ||
12-Month Risk Adjusted Momentum | 62.85% |
True Yield
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -3.73% |
Financial Health Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |